Given the association between high p53 protein expression and aggressive tumor behavior, a more aggressive therapeutic approach is warranted for patients diagnosed with non-muscle-invasive UC (high-grade papillary UC) of the bladder who exhibit high scores and intensities of p53 protein upon IHC evaluation. This evidence concerns the gene TP53 and neoplasm.